According to Standard BioTools's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.8677. At the end of 2024 the company had a P/S ratio of 3.88.
Year | P/S ratio | Change |
---|---|---|
2024 | 3.88 | 142.8% |
2023 | 1.60 | 68.89% |
2022 | 0.9472 | -58.98% |
2021 | 2.31 | -28.68% |
2020 | 3.24 | 55.92% |
2019 | 2.08 | -44.85% |
2018 | 3.76 | 68.59% |
2017 | 2.23 | 10.03% |
2016 | 2.03 | -25.33% |
2015 | 2.72 | -66.89% |
2014 | 8.21 | -40.86% |
2013 | 13.9 | 102.13% |
2012 | 6.87 | 10.5% |
2011 | 6.22 |